Increased Risk of Central Serous Chorioretinopathy among Patients with Nonorganic Sleep Disturbance.
Journal
Journal of ophthalmology
ISSN: 2090-004X
Titre abrégé: J Ophthalmol
Pays: United States
ID NLM: 101524199
Informations de publication
Date de publication:
2020
2020
Historique:
received:
24
09
2019
revised:
06
01
2020
accepted:
18
01
2020
entrez:
28
2
2020
pubmed:
28
2
2020
medline:
28
2
2020
Statut:
epublish
Résumé
Patients with central serous chorioretinopathy (CSC) typically present with acute visual impairment and metamorphopsia. The disease previously has been associated with psychological stress. Population-based cohort studies on the risk of CSC among patients with nonorganic sleep disturbance (NOSD) are limited. An early sign of psychiatric disorder was probably sleep disturbance. Furthermore, psychological stress may be caused by sleep disturbance. We investigated the relationship between NOSD and the incidence of CSC. Longitudinal cohort study. The difference in sex, age group, comorbidities, and steroid use between the two groups was analyzed by the During a mean follow-up of 7.36 ± 2.88 years, NOSD patients had a higher incidence of CSC than the controls (3.10 vs. 1.86 per 10,000 person-years; adjusted HR, 1.65; 95% CI, 1.34-2.02). Men had a higher risk of CSC than women. Sensitivity analyses stratified by sex, age group, or comorbidity condition showed consistently that NOSD patients had a higher risk of CSC than their controls. Dose-response showed that higher NOSD severity had even higher CSC risk. NOSD is an independent indicator for the increased risk of subsequent CSC development.
Identifiants
pubmed: 32104592
doi: 10.1155/2020/1712503
pmc: PMC7038385
doi:
Types de publication
Journal Article
Langues
eng
Pagination
1712503Informations de copyright
Copyright © 2020 Peng-Tai Tien et al.
Déclaration de conflit d'intérêts
The authors declare no conflicts of interest.
Références
Semin Ophthalmol. 2014 Mar;29(2):73-6
pubmed: 23758338
Retina. 2002 Feb;22(1):19-24
pubmed: 11884873
Soc Sci Med. 1976 May;10(5):239-44
pubmed: 968513
J Huazhong Univ Sci Technolog Med Sci. 2003;23(3):313-6
pubmed: 14526445
Br J Ophthalmol. 2003 Jun;87(6):709-12
pubmed: 12770966
Br J Ophthalmol. 2012 Dec;96(12):1484-8
pubmed: 22976583
N Engl J Med. 2000 May 11;342(19):1378-84
pubmed: 10805822
Am J Ophthalmol. 2016 May;165:23-8
pubmed: 26915576
Ophthalmology. 2008 Jan;115(1):169-73
pubmed: 18166410
JAMA. 1989 Sep 15;262(11):1479-84
pubmed: 2769898
Retina. 2014 Sep;34(9):1867-74
pubmed: 24743638
J Clin Endocrinol Metab. 2009 Nov;94(11):4234-42
pubmed: 19820009
Eye (Lond). 2010 Dec;24(12):1743-56
pubmed: 20930852
Acta Ophthalmol. 2008 Mar;86(2):126-45
pubmed: 17662099
Korean J Ophthalmol. 2018 Aug;32(4):281-289
pubmed: 30091306
Am J Respir Crit Care Med. 2007 Jan 15;175(2):190-5
pubmed: 17068329
Sleep Breath. 2007 Dec;11(4):253-7
pubmed: 17457629
PLoS One. 2013 Jun 24;8(6):e66858
pubmed: 23826160
Arch Ophthalmol. 1993 Sep;111(9):1229-33
pubmed: 8363466
Graefes Arch Clin Exp Ophthalmol. 2008 Sep;246(9):1225-8
pubmed: 18546012
Am J Ophthalmol. 1999 Jul;128(1):63-8
pubmed: 10482095
Retina. 2015 Feb;35(2):238-43
pubmed: 25127049
Acta Med Scand Suppl. 1982;660:69-83
pubmed: 6982602
Br J Ophthalmol. 2014 Jan;98(1):110-4
pubmed: 24169652
Ophthalmology. 2004 Feb;111(2):244-9
pubmed: 15019370
Arch Ophthalmol. 1994 Aug;112(8):1057-62
pubmed: 8053819
Am J Psychiatry. 1979 Oct;136(10):1257-62
pubmed: 314756
Retina. 2016 Jan;36(1):9-19
pubmed: 26710181
Retina. 2015 Feb;35(2):231-7
pubmed: 25099218
Br J Ophthalmol. 1997 Nov;81(11):962-4
pubmed: 9505819
Korean J Ophthalmol. 2012 Aug;26(4):260-4
pubmed: 22870024
Arch Gen Psychiatry. 1985 Mar;42(3):225-32
pubmed: 2858188